Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Haemonetics
HAE
$4B
| $17.6M | 0.02% |
176,847
-12,124
| -6% | -$1.31M |
|
227
Rogers Corp
ROG
$2.4B
| $16.9M | 0.02% |
178,932
-37,819
| -17% | -$4.3M |
|
|
CADE
228
DELISTED
Cadence Bank
CADE
| $16.8M | 0.02% |
885,483
-12,672
| -1% | -$335K |
|
229
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
| $16.6M | 0.02% |
337,550
+61,216
| +22% | +$3.61M |
|
230
Ecopetrol
EC
$34.5B
| $16.5M | 0.02% |
1,730,272
+79,773
| +5% | +$1.32M |
|
231
RLJ Lodging Trust
RLJ
$1.69B
| $16M | 0.02% |
2,072,829
-132,858
| -6% | -$1.78M |
|
232
Prosperity Bancshares
PB
$8.86B
| $15.7M | 0.02% |
325,840
-11,973
| -4% | -$779K |
|
233
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
| $15.5M | 0.02% |
263,412
+46,508
| +21% | +$3.5M |
|
234
AeroVironment
AVAV
$9.45B
| $15.5M | 0.02% |
253,724
+12,587
| +5% | +$787K |
|
235
Viavi Solutions
VIAV
$9.66B
| $15.1M | 0.02% |
1,346,014
-91,472
| -6% | -$1.24M |
|
|
MNDT
236
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $15M | 0.02% |
1,419,061
-260,344
| -16% | -$3.74M |
|
237
Omnicell
OMCL
$1.68B
| $14.8M | 0.02% |
225,999
-91,044
| -29% | -$7.25M |
|
|
238
HSBC
HSBC
$356B
| $14.8M | 0.02% |
529,032
-15,448,961
| -97% | -$537M |
|
239
ON Semiconductor
ON
$19.3B
| $14.3M | 0.02% |
1,150,063
+21,865
| +2% | +$428K |
|
240
Wintrust Financial
WTFC
$10.7B
| $14.2M | 0.02% |
433,434
-9,510
| -2% | -$528K |
|
241
Berkshire Hathaway Class B
BRK.B
$1.13T
| $14.2M | 0.02% |
77,699
-979
| -1% | -$208K |
|
242
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.36B
| $14M | 0.02% |
724,204
+90,274
| +14% | +$2.27M |
|
|
WDR
243
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $13.9M | 0.02% |
1,219,078
-142,438
| -10% | -$2.12M |
|
244
Amgen
AMGN
$222B
| $13.8M | 0.02% |
67,984
-46,782
| -41% | -$10.2M |
|
245
Wipro
WIT
$20B
| $13.7M | 0.02% |
8,850,444
-142,202
| -2% | -$250K |
|
|
PRAH
246
DELISTED
PRA Health Sciences, Inc.
PRAH
| $13.6M | 0.02% |
163,887
-8,555
| -5% | -$834K |
|
|
PFPT
247
DELISTED
Proofpoint, Inc.
PFPT
| $13.4M | 0.02% |
130,741
-8,098
| -6% | -$944K |
|
248
UMB Financial
UMBF
$11.1B
| $13.4M | 0.02% |
288,451
+285
| +0.1% | +$17.3K |
|
249
AAR Corp
AIR
$5.76B
| $13.2M | 0.02% |
744,654
-66,422
| -8% | -$2.43M |
|
250
Merit Medical Systems
MMSI
$5.32B
| $13M | 0.02% |
417,490
-20,115
| -5% | -$717K |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.